Nurix Therapeutics Inc (NRIX) Ownership

19.51 ↑0.67 (3.56%)

As of December 31, 1969, 7:00pm EST.

Institutions
Mutual Funds

Institutional Ownership

BlackRock Inc is the biggest individual institutional holder of Nurix Therapeutics Inc (NRIX), owning a total of 6.8 million shares. Combined, the top 37 institutional holders of NRIX own 102.69% of the company with a total of 67.7 million shares.

In the latest ownership report on September 30th 2024, the top 37 institutional holders decreased their combined ownership of NRIX by 5 thousand shares. 9 institutions bought 4,144,162 total additional shares and increased their ownership by an average of 17.04%. However 9 institutions sold 4,148,778 total shares and decreased their ownership by an average of 17.47%.

Overall this is a negative sign as the number of shares owned by the top 20 institutional holders of Nurix Therapeutics Inc decreased by a net total of -4,616 in the latest quarter.

Institution Ownership Chart

Latest Institutional Ownership Changes

Owner	Percent Owned	Percent Change	Shares Owned	Share Change	Date Reported
Redmile Group, LLC	6.044%	-3.224%	4,280,981	-142,635	2024-09-30
Vanguard Group Inc	5.664%	10.670%	4,011,814	386,800	2024-09-30
Baker Bros Advisors LP	5.480%	0.000%	3,882,125	0	2024-09-30
Deep Track Capital, LP	5.461%	-3.092%	3,868,104	-123,396	2024-09-30
Wellington Management Company LLP	4.916%	8.752%	3,482,105	280,240	2024-09-30
T. Rowe Price Associates, Inc.	4.333%	8.248%	3,068,961	233,842	2024-09-30
T. Rowe Price Investment Management,Inc.	3.597%	16.394%	2,548,091	358,899	2024-09-30
State Street Corp	3.348%	-12.452%	2,371,271	-337,262	2024-09-30
ARK Investment Management LLC	3.129%	-4.604%	2,216,365	-106,967	2024-09-30
Morgan Stanley - Brokerage Accounts	2.652%	-52.793%	1,878,564	-2,100,836	2024-09-30
Pictet Asset Manangement SA	2.525%	52.408%	1,788,530	615,012	2024-09-30
COMMODORE CAPITAL LP	2.329%	0.000%	1,650,000	1,650,000	2024-09-30
Citadel Advisors Llc	2.162%	47.137%	1,531,205	490,539	2024-09-30
Geode Capital Management, LLC	2.044%	9.556%	1,448,040	126,306	2024-09-30
Driehaus Capital Management LLC	1.815%	0.197%	1,285,632	2,524	2024-09-30
Soleus Capital Management, L.P.	1.505%	-48.158%	1,065,834	-990,082	2024-09-30
Candriam Luxembourg S.C.A.	1.499%	-8.786%	1,061,959	-102,287	2024-09-30
Affinity Asset Advisors, LLC	1.215%	-5.658%	860,399	-51,601	2024-09-30
Deutsche Bank AG	1.207%	-18.477%	854,682	-193,712	2024-09-30

Top Institutions

Owner	Percent Owned	Percent Change	Shares Owned	Share Change	Date Reported
BlackRock Inc	9.628%	48.895%	6,820,015	2,239,601	2024-06-30
Redmile Group, LLC	6.044%	-3.224%	4,280,981	-142,635	2024-09-30
Vanguard Group Inc	5.664%	10.670%	4,011,814	386,800	2024-09-30
Baker Bros Advisors LP	5.480%	0.000%	3,882,125	0	2024-09-30
Deep Track Capital, LP	5.461%	-3.092%	3,868,104	-123,396	2024-09-30
Wellington Management Company LLP	4.916%	8.752%	3,482,105	280,240	2024-09-30
T. Rowe Price Associates, Inc.	4.333%	8.248%	3,068,961	233,842	2024-09-30
Wasatch Advisors Inc.	5.624%	-22.860%	2,749,745	-814,871	2023-12-31
State Street Corporation	4.237%	196.241%	2,729,336	1,808,014	2024-03-31
T. Rowe Price Investment Management,Inc.	3.597%	16.394%	2,548,091	358,899	2024-09-30
State Street Corp	3.348%	-12.452%	2,371,271	-337,262	2024-09-30
ARK Investment Management LLC	3.129%	-4.604%	2,216,365	-106,967	2024-09-30
TRV GP III, LLC	4.078%	0.000%	1,922,549	0	2022-06-30
Morgan Stanley - Brokerage Accounts	2.652%	-52.793%	1,878,564	-2,100,836	2024-09-30
Pictet Asset Manangement SA	2.525%	52.408%	1,788,530	615,012	2024-09-30
COMMODORE CAPITAL LP	2.329%	0.000%	1,650,000	1,650,000	2024-09-30
Citadel Advisors Llc	2.162%	47.137%	1,531,205	490,539	2024-09-30
Geode Capital Management, LLC	2.044%	9.556%	1,448,040	126,306	2024-09-30
Driehaus Capital Management LLC	1.815%	0.197%	1,285,632	2,524	2024-09-30
Boxer Capital LLC	2.505%	0.000%	1,224,892	0	2023-09-30
Bain Capital Life Sciences Investors, LLC	1.758%	-37.879%	1,132,397	-690,486	2024-03-31
Soleus Capital Management, L.P.	1.505%	-48.158%	1,065,834	-990,082	2024-09-30
Candriam Luxembourg S.C.A.	1.499%	-8.786%	1,061,959	-102,287	2024-09-30
Nuveen Asset Management, LLC	1.385%	134.268%	981,167	562,344	2024-06-30
Dimensional Fund Advisors, Inc.	1.500%	-3.359%	966,453	-33,591	2024-03-31
Affinity Asset Advisors, LLC	1.215%	-5.658%	860,399	-51,601	2024-09-30
Wasatch Advisors LP	1.332%	-30.619%	858,067	-378,686	2024-06-30
Deutsche Bank AG	1.207%	-18.477%	854,682	-193,712	2024-09-30
TCG Crossover Management, LLC	1.175%	0.000%	717,654	717,654	2023-12-31
Foresite Capital Management IV, LLC	1.436%	-34.309%	677,143	-353,655	2022-06-30
Millennium Management LLC	1.329%	39.606%	644,411	182,819	2023-06-30
Charles Schwab Investment Management Inc	0.997%	3.197%	642,190	19,893	2024-03-31
Dafna Capital Management LLC	1.139%	0.000%	556,695	0	2023-09-30
Bank of America Corp	1.118%	-7.070%	546,450	-41,575	2023-09-30
Goldman Sachs Group Inc	0.765%	-12.617%	492,666	-71,134	2024-03-31
Northern Trust Corp	0.902%	2.849%	440,852	12,210	2023-09-30
FMR Inc	0.859%	-53.735%	416,613	-483,875	2023-06-30

Mutual Fund Ownership

ARK Genomic Revolution is the biggest individual fund holder of Nurix Therapeutics Inc (NRIX), owning a total of 2.2 million shares. Combined, the top 45 mutual fund holders of NRIX own 54.73% of the company with a total of 35 million shares.

In the latest ownership report on November 30th 2024, the top 45 fund holders increased their combined ownership of NRIX by 4 thousand shares. 2 funds bought 15,191 total additional shares and increased their ownership by an average of 0.76%. However 1 funds sold 11,353 total shares and decreased their ownership by an average of 0.56%.

Overall this is a positive sign as the number of shares owned by the top 20 mutual funds holding Nurix Therapeutics Inc increased by a net total of 3,838 in the latest report.

Mutual Funds Chart

Latest Mutual Fund Ownership Changes

Owner	Percent Owned	Percent Change	Shares Owned	Share Change	Date Reported
Vanguard Total Stock Mkt Idx Inv	2.862%	-0.557%	2,027,314	-11,353	2024-11-30
iShares Russell 2000 ETF	2.528%	0.000%	1,790,843	0	2024-11-30
ARK Genomic Revolution ETF	2.324%	0.000%	1,646,053	0	2024-11-30
SPDR® S&P Biotech ETF	1.443%	1.443%	1,021,783	14,532	2024-11-30
Vanguard Institutional Extnd Mkt Idx Tr	1.281%	0.073%	907,126	659	2024-11-30
BlackRock Health Sciences Opps Inv A	0.875%	0.000%	619,557	0	2024-11-30

Top Mutual Funds

Owner	Percent Owned	Percent Change	Shares Owned	Share Change	Date Reported
ARK Genomic Revolution	3.108%	-4.144%	2,201,225	-95,171	2024-09-30
Vanguard Total Stock Mkt Idx Inv	2.862%	-0.557%	2,027,314	-11,353	2024-11-30
iShares Russell 2000 ETF	2.528%	0.000%	1,790,843	0	2024-11-30
ARK Genomic Revolution ETF	2.324%	0.000%	1,646,053	0	2024-11-30
Vanguard Instl Ttl Stck Mkt Idx Tr	3.240%	29.436%	1,571,546	357,400	2023-03-31
US Small-Cap Growth II Equity Comp	2.052%	-0.354%	1,453,367	-5,168	2024-09-30
T. Rowe Price New Horizons	2.050%	-0.065%	1,452,424	-943	2024-10-31
Eventide Healthcare & Life Sciences I	2.448%	-38.289%	1,154,000	-716,000	2022-06-30
Fidelity Advisor Biotechnology I	1.463%	171.361%	1,036,600	654,600	2024-10-31
SPDR® S&P Biotech ETF	1.443%	1.443%	1,021,783	14,532	2024-11-30
Pictet-Biotech P USD	1.407%	0.776%	996,964	7,680	2024-08-31
Fidelity Select Health Care	1.373%	0.000%	972,634	972,634	2024-10-31
Vanguard Institutional Extnd Mkt Idx Tr	1.281%	0.073%	907,126	659	2024-11-30
Wasatch Small Cap Growth Investor	1.852%	-2.514%	898,101	-23,160	2023-09-30
Fidelity Select Biotechnology	1.079%	515.579%	764,217	640,071	2024-10-31
Wasatch Small Cap Value	1.430%	29.273%	702,910	159,168	2023-12-31
Fidelity Small Cap Index	0.918%	4.890%	650,393	30,320	2024-09-30
Candriam Global Equities Oncology	0.882%	-14.067%	624,817	-102,279	2024-09-30
Belfius Equities Cure C Cap	0.882%	0.000%	624,817	0	2024-10-31
Pictet-Global Megatrend Sel I USD	0.877%	0.209%	621,384	1,296	2024-08-31
BlackRock Health Sciences Opps Inv A	0.875%	0.000%	619,557	0	2024-11-30
Vanguard Extended Market Index Investor	1.278%	-0.029%	616,077	-181	2023-08-31
T. Rowe Price US Small-Cap Core Equity	0.853%	0.000%	603,858	603,858	2024-09-30
T. Rowe Price Small-Cap Stock	0.851%	-0.165%	602,863	-995	2024-10-31
Fidelity Advisor Health Care I	0.844%	0.000%	597,808	597,808	2024-10-31
UBS: US Equity Small Cap Growth	1.205%	0.000%	589,176	0	2023-09-30
Wasatch Ultra Growth	0.818%	-37.048%	548,977	-323,075	2024-06-30
Xtrackers MSCI World Swap ETF 1C	0.759%	0.000%	537,680	0	2024-10-31
Nuveen Quant Small Cap Equity R6	0.812%	0.000%	523,100	0	2024-07-31
T. Rowe Price Small-Cap Value	0.717%	-5.270%	507,751	-28,249	2024-10-31
TIAA-CREF Quant Small-Cap Equity Instl	1.026%	20.000%	501,610	83,600	2024-01-31
T. Rowe Price Integrated US SmCapGrEq	0.696%	88.632%	492,854	231,576	2024-09-30
T. Rowe Price Integrated US Sm Gr Eq	0.696%	22.944%	492,854	91,976	2024-09-30
Xtrackers S&P Global Infra Swap ETF 1C	0.751%	0.000%	483,688	0	2023-12-31
Fidelity® Small Cap Index	0.940%	1.146%	456,111	5,168	2023-10-31
iShares Biotechnology ETF	0.631%	-0.594%	447,133	-2,670	2024-10-31
Candriam Eqs L Biotech C USD Cap	0.652%	0.000%	437,107	0	2024-08-31
iShares Russell 2000 Value ETF	0.706%	-0.133%	431,115	-572	2024-05-30
Pictet Biotech	0.601%	0.000%	403,257	403,257	2024-03-31
BlackRock Health Sciences Term Trust	0.601%	0.000%	387,016	0	2024-05-31
Fidelity® Select Biotechnology	0.756%	0.000%	366,646	0	2023-08-31
Wasatch Micro Cap	0.717%	27.338%	352,482	75,673	2023-12-31
Nuveen Quant Small Cap Equity Instl	0.501%	-38.987%	306,050	-195,560	2024-02-29
State St Russell Sm/Mid Cp® Indx NL Cl C	0.482%	0.000%	294,513	0	2024-04-30
Schwab Small-Cap Equity	0.467%	6.284%	284,889	16,843	2024-03-31